Treatment challenges for community oncologists treating postmenopausal women with endocrine-resistant, hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer

Gradishar WJ

Cancer Management and Research 2016, 8:85-94

Published Date: 11 July 2016